Cervical Cancer Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Cervical Cancer Treatment Market By Disease Indication (Pre-malignant Lesions, Early Invasive Stage, Advanced Invasive Stage), By Treatment Type (Simple Hysterectomy, Radical Trachelectomy, Cryotherapy, Laser Surgery, Cold Knife Cone Biopsy, Cone Biopsy, LEEP (Loop Electrosurgical Exclusion Procedure), Chemotherapy, Hormone Therapy, Radiation Therapy, Targeted Therapy, Others), By End User (Hospitals, Ambulatory Surgical Centers, Pharmacies) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Cervical Cancer Treatment Market Outlook:

Cervical cancer is characterized by the growth of abnormal cells in the cervix region. It is most commonly occur in women due to Human Papilloma Virus (HPV) infection. Most common symptoms associated with cervical cancer include pelvic pain, vaginal bleeding, abnormal vaginal discharge, and pain during the sexual intercourse. Cervical cancer can be treated by chemotherapy, radiation therapy, and surgery among others. Cervical cancer treatment market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on global market gives historical, current, and future market sizes (US$ Bn) of disease indication (pre-malignant lesions, early invasive stage, advanced invasive stage), by treatment type (simple hysterectomy, radical trachelectomy, cryotherapy, laser surgery, cold knife cone biopsy, cone biopsy, leep (loop electrosurgical exclusion procedure), chemotherapy, hormone therapy, radiation therapy, targeted therapy, others), by end user (hospitals, ambulatory surgical centers, pharmacies) and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply.

Cervical Cancer Treatment Market

MARKET SUMMARY
-
X
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– X%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Cervical Cancer Treatment Market Analysis

  • The major market participants are adopting the strategies such as mergers and acquisitions to position themselves as strong players.
  • In May 2017, Bristol Myers Squibb and Advaxis entered into a clinical collaboration to evaluate ADXS-DUAL and Opdivo in metastatic cervical cancer.
  • Asia Pacific cervical cancer treatment market has a lucrative growth attributed to large patient pool, rise in medical tourism in Asia Pacific countries due to low cost of treatment, and entry of market players into Asia Pacific region are expected to bolster the market.
Market Leaders
  • GlaxoSmithKline Plc (UK)
  • Allergan Plc (UK)
  • Eli Lilly and Company (U.S.)
  • Pfizer, Inc. (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Genentech USA (U.S.)
  • Novartis  AG (Switzerland)
Cervical Cancer Treatment Market

Drivers and Restraints

Increase in the prevalence of cervical cancer around the world is mainly drives the global cervical cancer treatment market. Moreover, advancements in the cervical cancer treatment, early stage disease diagnosis, promising pipeline products, and government initiations for increase the cervical cancer treatment awareness are anticipated to fuel global cervical cancer treatment market over the forecast years. However, high cost for cervical cancer treatment, stringent regulatory guidelines for product approval, entry of generics into the market and adverse effects associated with radiation therapy are expected to restrain the growth of global cervical cancer treatment market.


Cervical Cancer Treatment Market Regional Analysis

North America dominates the market

North America cervical cancer treatment market is anticipated to expand at healthy growth rate due to increase in the prevalence of cervical cancer (according to Centers for Disease Control and Prevention 2014, approximately 12,578 women are diagnosed with cervical cancer), technological advancements for early stage disease diagnosis, and increase in R&D expenditure for the innovation of newer products are anticipated to fuel the market. Europe cervical cancer treatment market driven by increase in the prevalence of cervical cancer in Europe (according to WHO Europe, approximately 28,000 women die from cervical cancer every year), expansion of business by market players, and adoption of newer technologies for surgical cancer treatment are expected to boost the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

FEATURES OF THE REPORT

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Cervical Cancer Treatment Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Table of Content
  2. Executive Summary
  3. Global Cervical Cancer Treatment Market Introduction
    • Global Cervical Cancer Treatment Market – Taxonomy
    • Global Cervical Cancer Treatment Market –Definitions
      • Disease Indication
      • Treatment Type
      • End User
  1. Global Cervical Cancer Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Cervical Cancer Treatment Market Dynamic Factors – Impact Analysis
    • Global Cervical Cancer Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Cervical Cancer Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Cervical Cancer Treatment Market, By Disease Indication, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Pre-malignant Lesions
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Early Invasive Stage
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Advanced Invasive Stage
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cervical Cancer Treatment Market Forecast, By Treatment Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Simple Hysterectomy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Radical Trachelectomy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cryotherapy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Laser Surgery
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cold Knife Cone Biopsy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cone Biopsy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • LEEP (Loop Electrosurgical Exclusion Procedure)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Chemotherapy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hormone Therapy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Radiation Therapy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Targeted Therapy
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cervical Cancer Treatment Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Surgical Centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cervical Cancer Treatment Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Cervical Cancer Treatment Market – Opportunity Analysis Index, By Disease Indication, By Treatment Type, By End User, and Region, 2018 – 2024
  2. North America Cervical Cancer Treatment MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pre-malignant Lesions
      • Early Invasive Stage
      • Advanced Invasive Stage
    • Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Simple Hysterectomy
      • Radical Trachelectomy
      • Cryotherapy
      • Laser Surgery
      • Cold Knife Cone Biopsy
      • Cone Biopsy
      • LEEP (Loop Electrosurgical Exclusion Procedure)
      • Chemotherapy
      • Hormone Therapy
      • Radiation Therapy
      • Targeted Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Pharmacies
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Cervical Cancer Treatment Market – Opportunity Analysis Index, By Disease Indication, By Treatment Type, By End User, and Country, 2018 – 2024
    • North America Cervical Cancer Treatment Market Dynamics – Trends
  3. Europe Cervical Cancer Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pre-malignant Lesions
      • Early Invasive Stage
      • Advanced Invasive Stage
    • Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Simple Hysterectomy
      • Radical Trachelectomy
      • Cryotherapy
      • Laser Surgery
      • Cold Knife Cone Biopsy
      • Cone Biopsy
      • LEEP (Loop Electrosurgical Exclusion Procedure)
      • Chemotherapy
      • Hormone Therapy
      • Radiation Therapy
      • Targeted Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Cervical Cancer Treatment Market – Opportunity Analysis Index, By Disease Indication, By Treatment Type, By End User, and Country, 2018 – 2024
    • Europe Cervical Cancer Treatment Market Dynamics – Trends
  4. Asia-Pacific Cervical Cancer Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pre-malignant Lesions
      • Early Invasive Stage
      • Advanced Invasive Stage
    • Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Simple Hysterectomy
      • Radical Trachelectomy
      • Cryotherapy
      • Laser Surgery
      • Cold Knife Cone Biopsy
      • Cone Biopsy
      • LEEP (Loop Electrosurgical Exclusion Procedure)
      • Chemotherapy
      • Hormone Therapy
      • Radiation Therapy
      • Targeted Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Pharmacies
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Cervical Cancer Treatment Market – Opportunity Analysis Index, By Disease Indication, By Treatment Type, By End User, and Country, 2018 – 2024
    • Asia-Pacific Cervical Cancer Treatment Market Dynamics – Trends
  5. Latin America Cervical Cancer Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pre-malignant Lesions
      • Early Invasive Stage
      • Advanced Invasive Stage
    • Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Simple Hysterectomy
      • Radical Trachelectomy
      • Cryotherapy
      • Laser Surgery
      • Cold Knife Cone Biopsy
      • Cone Biopsy
      • LEEP (Loop Electrosurgical Exclusion Procedure)
      • Chemotherapy
      • Hormone Therapy
      • Radiation Therapy
      • Targeted Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Cervical Cancer Treatment Market – Opportunity Analysis Index, By Disease Indication, By Treatment Type, By End User, and Country, 2018 – 2024
    • Latin America Cervical Cancer Treatment Market Dynamics – Trends
  6. Middle East and Africa Cervical Cancer Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Pre-malignant Lesions
      • Early Invasive Stage
      • Advanced Invasive Stage
    • Treatment Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Simple Hysterectomy
      • Radical Trachelectomy
      • Cryotherapy
      • Laser Surgery
      • Cold Knife Cone Biopsy
      • Cone Biopsy
      • LEEP (Loop Electrosurgical Exclusion Procedure)
      • Chemotherapy
      • Hormone Therapy
      • Radiation Therapy
      • Targeted Therapy
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Cervical Cancer Treatment Market – Opportunity Analysis Index, By Disease Indication, By Treatment Type, By End User, and Country, 2018 – 2024
    • MEA Cervical Cancer Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Disease Indication& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • GlaxoSmithKline Plc (UK)
      • Allergan Plc (UK)
      • Eli Lilly and Company (U.S.)
      • Pfizer, Inc. (U.S.)
      • Bristol-Myers Squibb Company (U.S.)
      • Genentech USA (U.S.)
      • Novartis  AG (Switzerland)
      • Hoffmann La Roche Ltd (Switzerland)
      • Biocon Ltd. (India)
      • Hetero Drugs Ltd. (India)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  1. Disclaimer
  2. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

Report

Company Profile

  • GlaxoSmithKline Plc (UK)
  • Allergan Plc (UK)
  • Eli Lilly and Company (U.S.)
  • Pfizer, Inc. (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Genentech USA (U.S.)
  • Novartis  AG (Switzerland)
  • Hoffmann La Roche Ltd (Switzerland)
  • Biocon Ltd. (India)
  • Hetero Drugs Ltd. (India)

Description

Cervical Cancer Treatment Market Outlook:

Cervical cancer is characterized by the growth of abnormal cells in the cervix region. It is most commonly occur in women due to Human Papilloma Virus (HPV) infection. Most common symptoms associated with cervical cancer include pelvic pain, vaginal bleeding, abnormal vaginal discharge, and pain during the sexual intercourse. Cervical cancer can be treated by chemotherapy, radiation therapy, and surgery among others. Cervical cancer treatment market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on global market gives historical, current, and future market sizes (US$ Bn) of disease indication (pre-malignant lesions, early invasive stage, advanced invasive stage), by treatment type (simple hysterectomy, radical trachelectomy, cryotherapy, laser surgery, cold knife cone biopsy, cone biopsy, leep (loop electrosurgical exclusion procedure), chemotherapy, hormone therapy, radiation therapy, targeted therapy, others), by end user (hospitals, ambulatory surgical centers, pharmacies) and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX